115 Broadway, Cambridge

Biogen, founded in 1978, was the first biotechnology company in Cambridge, and in many ways, it created the mold for the life science businesses that dominate Kendall Square to this day. The company exploits fundamental insights into gene and protein expression to design monoclonal antibodies and other medicines for the treatment of neurological and neuromuscular diseases, hematologic diseases, and cancer. Its Cambridge campus includes this facility at 115 Broadway as well as its world headquarters office at 225 Binney Street. 

Guest speakers

Phillip Sharp, Institute Professor emeritus, Department of Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; Co-founder, Biogen; Nobel Prize winner, 1993

Walter Gilbert, Professor, Department of Molecular and Cellular Biology, Harvard University; Co-founder, Biogen; Nobel Prize winner, 1980